
CWAN Stock Forecast & Price Target
CWAN Analyst Ratings
Bulls say
Clearwater Analytics has demonstrated strong financial performance, with total revenue increasing by 72% year-over-year to $218 million, surpassing both forecasts and consensus by $1 million. The company reported a significant adjusted EBITDA growth of 71% year-over-year, reaching $248 million, while adjusted EBITDA margins improved to 33.9%, despite the lower margins from recent acquisitions. Furthermore, adjusted EBITDA for the quarter increased by 78% year-over-year to $74 million, also exceeding expectations, which underscores Clearwater's robust operational efficiency and market position within the investment technology sector.
Bears say
Clearwater Analytics Holdings is facing a challenging outlook due to increased financial leverage, with a net debt to EBITDA ratio exceeding 4x following recent acquisitions. The significant investment of $2.1 billion in acquiring Enfusion, Beacon, and Bistro has created risks associated with integration and management focus that could impede the company's ability to achieve operational goals. Additionally, declining capital market activity, asset manager assets under management (AUM), and insurance company performance further threaten growth and profitability, contributing to a nearly 50% decline in share value from recent peaks.
This aggregate rating is based on analysts' research of Clearwater Analytics Holdings and is not a guaranteed prediction by Public.com or investment advice.
CWAN Analyst Forecast & Price Prediction
Start investing in CWAN
Order type
Buy in
Order amount
Est. shares
0 shares